Kathleen V Fitch1. 1. Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, 5 Longfellow Place, Boston, MA, 02114, USA. kfitch@mgh.harvard.edu.
Abstract
PURPOSE OF REVIEW: Metabolic comorbidities including diabetes, obesity, dyslipidemia, and hypertension, all of which are traditional cardiovascular disease risk factors that are highly prevalent in people with HIV (PWH). Bone disease including osteopenia, osteoporosis, and fragility fractures is also prevalent in PWH. These comorbidities may be prevented and treated in part with lifestyle modification, including changes to dietary and physical habits. The purpose of this review is to highlight recent literature that characterizes current lifestyle habits in PWH as well as the effectiveness of lifestyle strategies to improve metabolic comorbidities prevalent in PWH. RECENT FINDINGS: Recent studies have expanded our knowledge regarding the current lifestyle habits of PWH as well as the potential for lifestyle modification to prevent or improve comorbidities prevalent in PWH. Clinical trials focusing on lifestyle modification have shown some benefit of such interventions on traditional risk factors for comorbidities; however, significant heterogeneity exists between studies and results are not consistent. Further clinical trials are needed including developing lifestyle strategies that are feasible, effective, and sustainable to prevent and decrease prevalence of comorbidities in this population.
PURPOSE OF REVIEW: Metabolic comorbidities including diabetes, obesity, dyslipidemia, and hypertension, all of which are traditional cardiovascular disease risk factors that are highly prevalent in people with HIV (PWH). Bone disease including osteopenia, osteoporosis, and fragility fractures is also prevalent in PWH. These comorbidities may be prevented and treated in part with lifestyle modification, including changes to dietary and physical habits. The purpose of this review is to highlight recent literature that characterizes current lifestyle habits in PWH as well as the effectiveness of lifestyle strategies to improve metabolic comorbidities prevalent in PWH. RECENT FINDINGS: Recent studies have expanded our knowledge regarding the current lifestyle habits of PWH as well as the potential for lifestyle modification to prevent or improve comorbidities prevalent in PWH. Clinical trials focusing on lifestyle modification have shown some benefit of such interventions on traditional risk factors for comorbidities; however, significant heterogeneity exists between studies and results are not consistent. Further clinical trials are needed including developing lifestyle strategies that are feasible, effective, and sustainable to prevent and decrease prevalence of comorbidities in this population.
Authors: Elena Alvarez; Waldo H Belloso; Mark A Boyd; Ahmet Ç Inkaya; Evelyn Hsieh; Andrew Kambugu; Greg Kaminski; Esteban Martinez; Hans-Jürgen Stellbrink; Sharon Walmsley; Todd T Brown; Patrick W G Mallon Journal: Curr Opin HIV AIDS Date: 2016-05 Impact factor: 4.283
Authors: Allison R Webel; Shirley M Moore; Chris T Longenecker; Jackson Currie; Christine Horvat Davey; Joseph Perazzo; Abdus Sattar; Richard A Josephson Journal: J Acquir Immune Defic Syndr Date: 2018-05-01 Impact factor: 3.731
Authors: Judith A Aberg; Jonathan E Kaplan; Howard Libman; Patricia Emmanuel; Jean R Anderson; Valerie E Stone; James M Oleske; Judith S Currier; Joel E Gallant Journal: Clin Infect Dis Date: 2009-09-01 Impact factor: 9.079
Authors: Joseph D Perazzo; Allison R Webel; Carl J Fichtenbaum; Grace A McComsey Journal: J Assoc Nurses AIDS Care Date: 2017-10-04 Impact factor: 1.809
Authors: Maria Mazzitelli; Mattia Trunfio; Cristina Putaggio; Lolita Sasset; Davide Leoni; Sara Lo Menzo; Daniele Mengato; Anna Maria Cattelan Journal: Biomedicines Date: 2022-07-28